Chronic kidney disease does not affect all populations equally. Black Americans develop kidney failure at three times the rate of white Americans, representing nearly 35% of dialysis patients while comprising 13% of the population. Understanding this disparity is the first step toward closing it.
The Role of APOL1
One of the most significant biological contributors is the APOL1 gene. Certain high-risk variants are carried by an estimated 13% of Black Americans. Those carrying two copies face dramatically elevated risk of focal segmental glomerulosclerosis (FSGS), lupus nephritis, and hypertension-associated kidney disease.
This genetic risk evolved in West Africa as protection against sleeping sickness. In the context of modern kidney health, these variants can predispose some individuals to accelerated kidney damage.
Structural and Access Barriers
Genetics alone does not explain the full picture. Black Americans also face higher rates of hypertension and diabetes, the two leading causes of kidney failure, often driven by limited access to preventive care, food deserts, and socioeconomic stressors.
Historical mistrust of the medical establishment, rooted in documented abuses including the Tuskegee study, also contributes to delayed diagnoses and lower rates of specialist care. This is a barrier the research community must actively work to dismantle.
Why Representation in Clinical Trials Matters
For decades, kidney disease trials enrolled predominantly white patients. The result: treatments whose effectiveness and safety for Black patients was extrapolated rather than proven. Increasing enrollment of Black Americans in CKD and APOL1 research is both an equity goal and a scientific necessity.
NuLine in Oakland Park actively recruits from South Florida’s diverse communities, including those disproportionately affected by kidney disease. Our team understands the cultural context and is committed to building trust through transparency and genuine compassion.
- Ask your doctor for an annual kidney function panel (eGFR and urine albumin)
- Know your APOL1 status if you have a family history of kidney disease
- See our current kidney studies